Could your aspirin be failing you? trinidad study investigates
NCT ID NCT06228820
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed pilot study looked at whether some healthy adults are resistant to aspirin's blood-thinning effects. 48 participants took two different types of 81 mg aspirin for two weeks each, and their platelet function was measured. The goal was to understand how common aspirin resistance is and how well lab tests can detect it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Aspirin (81 mg enteric-coated and 81 mg Vazalore aspirin)
- What this could lead to
- If successful, this could help identify why some people don't respond well to aspirin, potentially improving heart attack and stroke prevention strategies.
- What could go wrong
- This is a small pilot study with only 48 healthy participants, so results may not apply to the general population or those with medical conditions. The tests used are not perfectly accurate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATELET DYSFUNCTION DUE TO DRUGS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of the West Indies
Saint Augustine, North, 00000, Trinidad and Tobago